Related Experiment Video
Updated: Sep 30, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Impact of COVID-19 on Affected Individuals in Iraq Focusing on Deceased Cancer Patients
Nada A S Alwan1, Faris Lami2, Hanan A Khaleel3
1National Cancer Research Center, University of Baghdad, Baghdad, Iraq.
Insights
COVID-19 mortality is high in elderly and comorbid patients. In Iraq, cancer patients who died from COVID-19 were younger and hospitalized longer than those with other conditions, highlighting health system gaps.
Area of Science:
- Epidemiology
- Oncology
- Infectious Diseases
Background:
- COVID-19 significantly increases mortality in elderly and comorbid populations.
- Cancer is a critical comorbidity influencing COVID-19 outcomes.
- Understanding these impacts is vital for public health strategies.
Purpose of the Study:
- To assess the impact of COVID-19 on deceased individuals in Iraq.
- To characterize COVID-19 deaths, focusing on cancer as a comorbidity.
Main Methods:
- Retrospective review of 15,852 COVID-19 deceased case investigation records in Iraq (March 2020–December 2021).
- Analysis of patient demographics, comorbidities, and hospitalization details.
- Chi-square tests used for statistical comparisons.
Main Results:
- 62% of deceased patients were ≥ 60 years; 63.2% were male.
- Cancer patients were younger (41.5% ≥ 60) and had longer hospital stays.
- Comorbidities were present in ~70% of deaths; cardiovascular diseases (49.7%) and diabetes (39.3%) were most common.
Conclusions:
- COVID-19 patients with cancer in Iraq were younger and hospitalized longer than those with other comorbidities.
- The pandemic exposed weaknesses in health information and surveillance systems.
- Strengthening emergency preparedness is crucial.
Purpose:
Mortality because of COVID-19 infections is continuously increasing among the high-risk groups, namely, elderly patients and those with underlying comorbidities including cardiovascular diseases, diabetes, respiratory problems, and cancer. The study aimed to assess the impact of COVID-19 on affected individuals in Iraq, focusing on the characteristics of COVID-19 deceased cases, with special emphasis on cancer as the associated comorbidity.
Patients And Methods:
This is a retrospective review of the data collected from 15,852 case investigation records of deceased patients with COVID-19, from all over Iraq, between March 20, 2020, and December 20, 2021. The analyzed variables included patients' age, sex, duration of stay in hospital, use of mechanical ventilation, and associated morbidities. Comparisons of having comorbidities and cancer with the characteristics were carried out using the chi-square test of independence. The chi-square test of goodness of fit was used to describe the distribution of the characteristics of the deceased COVID-19 patients; P values < .05 were considered statistically significant.
Results:
Overall, 62% were ≥ 60 years with a predominance of male (63.2%). Patients with cancer were significantly younger (41.5% were ≥ 60) with no difference concerning sex distribution. Almost 70% of patients who died from COVID-19 infection had associated comorbidities. Cardiovascular diseases, diabetes, chronic obstructive pulmonary diseases, and cancer constituted 49.7%, 39.3%, 2.9%, and 1.1%, respectively. Patients with a history of cancer had a significantly longer duration of stay in hospital with no statistical association regarding the use of ventilation.
Conclusion:
In Iraq, patients with cancer infected with COVID-19 were younger and spent longer durations in the hospital before they died than patients with other comorbidities. The pandemic has revealed significant gaps in the health information and surveillance systems that demand prompt strengthening as part of the emergency preparedness.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Psychoneuroimmunology: Diabetes and Cancer
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

